MAPT and Dravet syndrome: Markers of tau pathology, however, namely pTau‐181 and pTau‐217, reliably differentiate between symptomatic and asymptomatic DS and have been reported to correlate well with tau and amyloid pathology as assessed by positron emission tomography (PET).14, 19, 20, 21